Lobbying disclosures · Lobbying report
CI: third_quarter 2026 lobbying report
Issues related to the health care marketplace and pharmacy benefit managers. Monitor issues related to Tricare pharmacy benefit.
Follow CI- Became public
- Oct 20, 2026, 12:29 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 3:30 PM EST
Why this is connected
Legal-name match: THE CIGNA GROUP is Cigna Group (https://www.sec.gov/Archives/edgar/data/1739940/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Income: $80,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/a5dcada0-7f15-4a43-9cad-6139fb27bca3/","filing_uuid":"a5dcada0-7f15-4a43-9cad-6139fb27bca3","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/a5dcada0-7f15-4a43-9cad-6139fb27bca3/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Katie Wise","dt_posted":"2026-10-20T12:29:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"975 F St NW","registrant_address_2":"Suite 550","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400693064,"url":"https://lda.gov/api/v1/registrants/400693064/","house_registrant_id":null,"name":"RED+BLUE STRATEGIES","description":"Health Care Consulting","address_1":"975 F St NW","address_2":"Suite 550","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MELANIE NATHANSON","contact_telephone":"+1 202-258-9381","dt_updated":"2026-05-30T12:28:54.268599-04:00"},"client":{"id":72415,"url":"https://lda.gov/api/v1/clients/72415/","client_id":72415,"name":"THE CIGNA GROUP","general_description":"Global health company","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the health care marketplace and pharmacy benefit managers. Monitor issues related to Tricare pharmacy benefit.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54544,"prefix":"ms","prefix_display":"MS.","first_name":"MELANIE","nickname":null,"middle_name":"JAN","last_name":"NATHANSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145382,"prefix":"ms","prefix_display":"MS.","first_name":"MEGAN","nickname":null,"middle_name":"HAUCK","last_name":"MARSHALL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151352,"prefix":null,"prefix_display":null,"first_name":"KATHRYN","nickname":null,"middle_name":null,"last_name":"WISE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149686,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"KLEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in CI
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Apr 30, 2026$1K–$15K
- Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 23, 2026 · disclosed Apr 30, 2026 · Dependent
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.